share_log

康泰生物:关于董事会提议向下修正可转换公司债券转股价格的公告

Shenzhen Kangtai Biological Products: Announcement on the board of directors proposing to revise the conversion price of convertible corporate bonds downward

SZSI ·  May 16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more